Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to assess the effectiveness of a pneumococcal conjugate vaccine (PCV10). We conducted a baseline carriage survey in rural (Kumbotso, Kano) and urban (Pakoto, Ogun) Nigeria. In this cross-sectional study, we obtained data on demography, clinical history, risk factors, and took NP swabs for pneumococcal culture. We calculated crude and age-standardised carriage prevalence and used log-binomial regression to assess risk factors for carriage. Among children aged 40% across all ages. The age-standardized prevalence of pneumococcal carriage was 66% in Kumbotso and 40% in Pakoto. The most commonly identified serotypes were 19 F, 6 A and 23 F. Risk fac...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to...
Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to...
BACKGROUND: Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerate...
<div><h3>Background</h3><p>Introduction of pneumococcal vaccines in Nigeria is a priority as part of...
Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerated Vaccine In...
Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerated Vaccine In...
BACKGROUND: We conducted an ancillary study among individuals who had participated in a PCV-7 trial ...
Streptococcus pneumoniae (pneumococcus) is a leading vaccine-preventable cause of childhood invasive...
Streptococcus pneumoniae (pneumococcus) is a leading vaccine-preventable cause of childhood invasive...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to...
Changes in nasopharyngeal (NP) carriage of vaccine-type (VT) Streptococcus pneumoniae can be used to...
BACKGROUND: Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerate...
<div><h3>Background</h3><p>Introduction of pneumococcal vaccines in Nigeria is a priority as part of...
Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerated Vaccine In...
Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerated Vaccine In...
BACKGROUND: We conducted an ancillary study among individuals who had participated in a PCV-7 trial ...
Streptococcus pneumoniae (pneumococcus) is a leading vaccine-preventable cause of childhood invasive...
Streptococcus pneumoniae (pneumococcus) is a leading vaccine-preventable cause of childhood invasive...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...